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Background: Salmonella and Shigella cause signiﬁcant morbidity and mortality among
childrenworldwide. Increased antimicrobial resistance results in greater burden of disease.
Materials and Methods: From 2005 to 2011, Salmonella and Shigella isolates collected
from ill children at a major hospital in Yucatan, Mexico, were subjected to serotyping and
antimicrobial susceptibility testing by disk diffusion and agar dilution. The identiﬁcation of
blaCTX, blaCMY, blaSHV, blaTEM, and blaOXA and qnr resistance genes was conducted by
PCR and sequencing.
Results: Among 2344 children with acute gastroenteritis, salmonellosis decreased from
17.7% in 2005 to 11.2% in 2011 (p < 0.001). In contrast, shigellosis increased from 8.3%
in 2010 to 12.1% in 2011. Compared to children with Salmonella, those with Shigella had
signiﬁcantlymore bloody stools (59 vs 36%, p< 0.001), dehydration (27 vs 15%, p = 0.031),
and seizures (11 vs 3%, p = 0.03). In Salmonella (n = 365), there was a signiﬁcant decrease
in resistance to ampicillin (43 to 16%, p < 0.001), trimethoprim–sulfamethoxazole (44 to
26%, p = 0.014), and extended-spectrum cephalosporins (27 to 10%, p = 0.009). Reduced
susceptibility to ciproﬂoxacin inSalmonella rose from30 to 41% (p< 0.001). All ceftriaxone-
resistant isolates harbored the blaCMY 2 gene. qnr genes were found in 42 (36%) of the−
117 Salmonella isolates with a ciproﬂoxacin MIC ≥ 0.125 μg/ml. Four were qnrA1 and 38
were qnrB19. Resistance to ampicillin (40%) and trimethoprim–sulfamethoxazole (58%)
was common in Shigella (n = 218), but isolates remained fully susceptible to ceftriaxone
and ciproﬂoxacin.
Conclusion: Illness from Salmonella has decreased while severe Shigella infections have
increased among children with gastroenteritis in the Yucatan Peninsula. While Shigella
resistance to clinically important antibiotics remained unchanged, resistance to most of
these, except ciproﬂoxacin, declined in Salmonella. blaCMY−2 and qnr genes are common
in Salmonella isolates.
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INTRODUCTION
Salmonella and Shigella are associated with a high burden of
illness among children in the developing world (Niyogi, 2005;
Woc-Colburn and Bobak, 2009; Kotloff et al., 2013). In Mexico,
the disease patterns of these pathogens have undergone signiﬁ-
cant changes in the last decades. During the early 1970s, Shigella
dysenteriae type 1 and Salmonella Typhi caused severe outbreaks
among the local population. The epidemic strains of S. Typhi and
S. dysenteriae were both multidrug resistant (MDR) to chloram-
phenicol, tetracycline, streptomycin, and sulfonamides, harbored
on different plasmids (Datta and Olarte, 1974). Subsequently, S.
dysenteriae infections decreased, while Shigella ﬂexneri became
the predominant species isolated from endemic infections. S.
dysenteriae, nonetheless, was still prevalent among visitors to the
Yucatan Peninsula during the late 1980s (Centers for Disease Con-
trol [CDC], 1988). Typhoid fever also sharply declined, while
non-typhoidal Salmonella, extremely prevalent along the food
chain, was identiﬁed as one of the main causes of gastroenteri-
tis in hospitalized children. Salmonella Typhimurium, commonly
carrying resistance to ampicillin, chloramphenicol, strepto-
mycin, sulfonamides, and tetracycline, was the most common
serotype encountered in Yucatan (Zaidi et al., 2006). Extended-
spectrum cephalosporin (ESC)-resistant S. Typhimurium isolates
ﬁrst emerged in 2002, and rapidly spread throughout the state
causing severe diarrhea and fatal systemic infections in infants
(Zaidi et al., 2007).
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In the past 25 years, the combination of the widespread use
of oral rehydration solutions, rising antimicrobial resistance, and
regional socioeconomic changes has modiﬁed the epidemiol-
ogy and the impact of these enteric pathogens (von Seidlein
et al., 2006; Parry and Threlfall, 2008). There is a clear need to
update relevant epidemiologic data (Sansonetti, 2006) as there
are few studies from Latin America. Monitoring for ESC and ﬂu-
oroquinolone resistance is particularly important because these
compounds are among the few therapeutic options available
for severe Salmonella and Shigella infections. In this study, the
main objectives were (1) to analyze trends in incidence and
antimicrobial resistance of Salmonella and Shigella infections
in children with gastroenteritis and/or systemic infections who
sought medical attention at a major hospital in the Yucatan
Peninsula, (2) to compare the clinical presentations of the ill chil-
dren, and (3) determine the prevalence of extended-spectrum
beta-lactamases, CMY-2 and Qnr in Salmonella and Shigella
isolates.
MATERIALS AND METHODS
SETTING
The Hospital General O’Horan is a tertiary-care public hospi-
tal that receives patients from throughout the state of Yucatan
and neighboring states in southeast Mexico. The Pediatrics Emer-
gencyDepartment has an active surveillance program for diarrheal
pathogens, current since 2000, which includes children with mild
to severe gastroenteritis as well as those with systemic infections.
Stool cultures are systematically collected from children with diar-
rhea. Blood cultures are also routinely collected from childrenwho
appear septic or develop hematological, neurological, or other
extraintestinal complications.
CLINICAL AND EPIDEMIOLOGICAL DATA
A trained nurse administered standardized questionnaires to
collect demographic and clinical information on the chil-
drens’diarrheal episodes.
MICROBIOLOGY
Stool samples were collected in sterile containers containing
Cary–Blair media. Samples were inoculated onto XLD, Hek-
toen Enteric, and brilliant green agars as well as tetrathion-
ate and Rappaport broths and incubated at 35◦C for 18–
24 h. Broths were subcultured to XLD and brilliant green agar
plates and incubated for another 18–24 h. Identiﬁcation of
Salmonella and Shigella isolates were performed with conven-
tional biochemical tests. Salmonella isolates were serotyped by
the Kauffman–White scheme using commercial antisera (Bec-
ton Dickinson, Franklin Lakes, NJ, USA). All Shigella isolates
were serogrouped; serotyping was performed on S. dysente-
riae isolates only. Antimicrobial susceptibility testing was rou-
tinely performed for ampicillin, chloramphenicol, gentamicin,
nalidixic acid, trimethoprim–sulfamethoxazole, ciproﬂoxacin,
ceftriaxone, ceftazidime, and tetracycline by disk diffusion
(CLSI, 2012a). Minimum inhibitory concentrations (MICs)
for ciproﬂoxacin, azithromycin, ceftriaxone, nalidixic acid,
and furazolidone were determined by agar dilution (CLSI,
2012b). Susceptibility and resistance breakpoints used for
azithromycin were 16 and 32 μg/ml, respectively (Sjolund-
Karlsson et al., 2011) and 2 μg/ml and 8 μg/ml for furazoli-
done (Rampling et al., 1990). Ceftriaxone and/or ceftazidime
non-susceptible isolates were tested on a secondary panel of
beta-lactam antimicrobials that included cefepime, cefotaxime,
cefoxitin, imipenem, meropenem, amoxicillin–clavulanic acid,
and piperacillin-tazobactam. According to resistance phenotypes,
these isolates were also screened for AmpC beta-lactamase pro-
duction with a combination disk method using cefoxitin (30 μg)
and cefoxitin with boronic acid (30 μg + 300 μg; Jacoby et al.,
2006).
GENETIC CHARACTERIZATION OF bla and qnr GENES
All ceftriaxone-resistant isolates (MIC ≥ 4) were tested for the
presence of beta-lactamase genes. A multiplex PCR was used for
the detection of genes encoding the CTX, SHV, TEM, and OXA
enzymes according to previously published methods (Briñas et al.,
2002; Edelstein et al., 2003). Detection of the blaCMY gene was
performed using a previously described assay (Zhao et al., 2001).
Salmonella isolates with ciproﬂoxacin MICs ≥ 0.125 μg/ml were
tested for qnrA,qnrB, and qnrS genes following publishedmethods
(Robicsek et al., 2006).
Speciﬁc group primers used for the study are listed in Table 1.
Control strains were kindly provided by Patrick McDermott (U.S.
Food andDrugAdministration) and Jesus Silva-Sanchez (Instituto
Nacional de Salud Publica, Mexico).
Ampliﬁed products were separated by gel electrophoresis
on 2% agarose and stained with ethidium bromide. Sequenc-
ing was performed using both forward and reverse PCR
primers on a ABI Prism 3130 XL Genetic Analyzer (Applied
Biosystems). Sequences were analyzed using the National Cen-
ter for Biotechnology Information’s BLAST network service
(http://www.ncbi.nlm.nih.gov/BLAST/). Sequences were com-
pared to the original gene sequences reported in the GenBank
database of accession numbers J01749, X91840, AY070235,
EU432277, FJ460235 (Sutcliffe, 1979; Bauernfeind et al., 1996;
Jacoby et al., 2008; Wiesner et al., 2009). Sequences for qnrA1 and
qnrB19 were submitted under accession numbers KF517418 and
KF517417, respectively.
DATA ANALYSIS
The chi-square test was used to detect resistance trends over time
and differences in clinical presentations for each pathogen; a p
value< 0.05was considered signiﬁcant. The odds ratio and its 95%
conﬁdence interval (CI) were calculated for the different clinical
variables. Antimicrobial susceptibility results were analyzed with
Whonet software version 5.6 (www.whonet.org).
ETHICS
The data was obtained from two different studies that were
approved by the Hospital General O’Horan Research and Ethics
Committee; written informed consent was obtained from the chil-
dren’s guardians to collect stool samples and use the data for
scientiﬁc purposes. For this analysis, clinical and microbiologi-
cal data were entered on new databases; a unique numerical code
was assigned to each patient and personal identiﬁers were removed
to ensure anonymity.
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Table 1 | Specific group primers used for PCR assays for beta-lactamase and qnr genes.
PCR name Primer name Sequence (5′–3′) Length (base) Amplicon size (pb)
Multiplex TEM, SHV, CTX, OXA tem-F TTCTTGAAGACGAAAGGGC 19 1150
tem-R ACGCTCAGTGGAACGAAAC 19
shv-F CACTCAAGGATGTATTGTG 19 702
shv-R TTAGCGTTGCCAGTGCTCG 19
ctx-F TTTGCGATGTGCAGTACCAGTAA 23 544
ctx-R CGATATCGTTGGTGGTGCCATA 22
oxa-F TTCAAGCCAAAGGCACGATAG 21 885
oxa-R TCCGAGTTGACTGCCGGGTTG 21
CMY cmy-F GACAGCCTCTTTCTCCACA 19 1000
cmy-R TGGAACGAAGGCTACGTA 18
Multiplex qnrA, qnrB and qnrS qnrA-F ATTTCTCACGCCAGGATTTG 20 516
qnrA-R GATCGGCAAAGGTTAGGTCA 20
qnrB-F GATCGTGAAAGCCAGAAAGG 20 469
qnrB-R ACGATGCCTGGTAGTTGTCC 20
qnrS-F ACGACATTCGTCAACTGCAA 20 417
qnrS-R TAAATTGGCACCCTGTAGGC 20
RESULTS
EPIDEMIOLOGY
From January 2005 to December 2011, 2344 children under 10
years of age who were admitted to the hospital for acute gas-
troenteritis were included in the study. One child with fever and
malaise without gastroenteritis, whose blood culture was positive
for S. Typhi, was also included. Children came from 94 locali-
ties within the state of Yucatan and from 35 other cities or towns
in the neighboring states. Eight hundred ninety-one (38%) were
under 1 year of age, 1176 (54%) were between 1 and 4 years of age,
and 186 (8%) were between 5 and 9 years of age. Salmonella gas-
troenteritis decreased from 17.7% of all cases in 2005 to 11.2% in
2011 (p< 0.001). Shigella infections increased during this period,
with a precipitous rise from 8.3% in 2010 to 12.1% in 2011, but
the difference was not statistically signiﬁcant (Figure 1A). A total
of 365 Salmonella and 218 Shigella isolates were collected. The
ﬁve most commonly isolated Salmonella serovars from ill chil-
dren remained constant; S. Typhimurium was consistently the top
serovar (19–21%) followed by S. Agona (9%), S. Muenchen (6–
7%), S.Muenster (6–11%), and S. Enteritidis (5–7%). The S. Typhi
isolate was susceptible to all tested antibiotics. Similarly, there was
no change in the distribution of Shigella species; S. ﬂexneri was
predominant (68–76%), followed by S. sonnei (16–17%), S. boydii
(5–12%), and S. dysenteriae (2%). S. dysenteriae strains belonged
to type 3 (two isolates) and type 2 (two isolates).
CLINICAL PRESENTATION
Prospectively obtained clinical data was available for 112 patients
with Shigella and 118 patients with Salmonella. Compared to chil-
dren with Salmonella, those with Shigella had more fever ≥ 38.5◦C
(36 vs 17%, p = 0.001, OR = 2.7, 95% CI = 1.4–5.3), bloody stools
(59 vs 36%, p< 0.001, OR = 2.6, 95% CI = 1.5–4.6), dehydration
(27 vs 15%, p = 0.031, OR = 2.0, 95% CI = 1.0–4.1), and almost
four times as many seizures (11 vs 3%, p = 0.03, OR = 3.4, 95%
CI = 0.98–13.0; Figure 1B).
ANTIMICROBIAL RESISTANCE
Ampicillin resistance in Salmonella decreased from 43% in 2005 to
16% in 2011 (p < 0.001), while trimethoprim–sulfamethoxazole
resistance decreased from 44% to 26% (p = 0.014). Likewise, resis-
tance to ceftriaxone and other ESC, most commonly observed
in S. Typhimurium, decreased from 27% to 10% (p = 0.009).
Trends for the different time periods throughout the study are
shown on Table 2 and Figures 2A–C. MIC50 and MIC90 values
for the whole study period were, respectively, 0.03 and 0.5 μg/ml
for ciproﬂoxacin, 0.125 and 64 μg/ml for ceftriaxone, and 8 and
16 μg/ml for azithromycin.
Reduced susceptibility to ciproﬂoxacin (MIC ≥ 0.12
and ≤ 1 μg/ml) was found in 113 Salmonella isolates evenly dis-
tributed throughout the study period; 77 of these (68%) were
resistant to nalidixic acid, and was most commonly seen in S.
Typhimurium (34%), S. Enteritidis (16%), S. Albany (9%), S.
Muenster (6%), S. Muenchen (5%), and S. Reading (5%).
The percentage of isolates with reduced susceptibility to
ciproﬂoxacin rose from 30% in 2005 to 41% in 2011 (p < 0.001).
The number of isolates with MIC ≥ 1 μg/ml, however, peaked
during 2007–2009 (14%) and then decreased in 2010–2011 (7%),
although the difference was not signiﬁcant (Figure 2A). Isolates
with ciproﬂoxacin MIC = 2 μg/ml were ﬁrst detected in 2007
in S. Anatum, and subsequently, in two MDR, ESC-resistant S.
Typhimurium strains (2008 and 2011), and one S. Enteritidis
strain (2009).
Sixty-one ceftriaxone and ceftazidime resistant isolates
were uniformly resistant to cefotaxime, cefoxitin, aztreonam,
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FIGURE 1 | Frequency and clinical presentation of Salmonella and
Shigella infections in ill children at a state referral hospital inYucatan,
Mexico, 2005–2011. (A)There was a statistically signiﬁcant trend toward
decreasing Salmonella gastroenteritis, from 17.7% in 2005 to 11.2% in 2011
(p < 0.001). In contrast, there was a precipitous increase in shigellosis from
8.3% in 2010 to 12.1% in 2011. (B) Children with Shigella had twice as much
fever ≥38.5◦C, bloody stools, dehydration, and almost four times as many
seizures, compared to those with Salmonella. Children with salmonellosis,
however, were more likely to be admitted with hypovolemic shock.
and amoxicillin/clavulanic acid; 52% were resistant to
piperacillin/tazobactam. All isolates were susceptible to cefepime,
imipenem, and meropenem, and were inhibited by cefoxitin in the
presence of boronic acid. Before 2005, ESC-resistance was limited
to S. Typhimurium; it was subsequently detected in S. Havana
(2005), S. Anatum (2007), S. Agona (2008), S. Enteritidis (2009),
and S. Weltevreden (2011).
Shigella isolates were frequently resistant to tetracycline,
ampicillin, furazolidone, and trimethoprim–sulfamethoxazole
(Table 3); all isolates were susceptible to ciproﬂoxacin, ceftriax-
one, and azithromycin. Only one isolate was resistant to nalidixic
acid. Resistance to furazolidone decreased from 56.1% in 2005
to 27.1% in 2011 (p < 0.001). There were few changes in the
MICdistributions for azithromycin, ceftriaxone, and ciproﬂoxacin
(Figures 3A–C), and no signiﬁcant resistance trends during the
different time periods (Table 3). MIC50 and MIC90 values for
the whole study period were, respectively, 0.03 and 0.03 μg/ml
for ciproﬂoxacin, 0.06 and 0.06 μg/ml for ceftriaxone, and 8 and
16 μg/ml for azithromycin.
PREVALENCE OF qnr AND BETA-LACTAMASE GENES
Of the 117 Salmonella isolates with a ciproﬂoxacin MIC between
0.125 and 2 μg/ml, 42 (36%) harbored qnr genes. Four (3%) car-
ried qnrA genes and 38 (32%) carried qnrB genes. The number of
isolateswith qnr genes peaked in 2007 (29%) anddecreased to 10%
by 2011 (p < 0.001). The qnrA genes, found in two serovars, were
99% identical to qnrA1 gene variants. qnrB genes, 99% identical to
qnrB19 variants,were distributed in 11different serovars (Table 4).
Both Qnr determinants presented 100% identity to the originally
reported amino acid sequences. All 61 ESC-resistant Salmonella
isolates carried a blaCMY gene. The sequences of all PCR prod-
ucts were 99% identical to the prototype blaCMY−2 gene and had
100% identity to the those obtained for blaCMY−2 genes found in
S. Typhimurium strains from Yucatan and three other states in
Mexico (Wiesner et al., 2009). Only one isolate also harbored a
TEM-1 gene; none harbored SHV, CTX, or OXA genes.
DISCUSSION
Illness from Salmonella has decreased in the Yucatan Penin-
sula while severe Shigella infections have increased among chil-
dren with gastroenteritis requiring hospitalization. There is a
high frequency of resistance to ampicillin and trimethoprim–
sulfamethoxazole in Shigella isolates, but these remain uniformly
susceptible to ESC,ciproﬂoxacin, and azithromycin.While Shigella
resistance to clinically important antibiotics over the last 7 years
remained basically unchanged, resistance to most of these, with
Table 2 | Antimicrobial susceptibility in Salmonella isolates from ill children inYucatan, Mexico, 2005–2011. Percentage of resistance*.
Year of isolation AMP† CRO‡ CAZ‡ AZT CIP NAL CHL FZD GEN STX§ TET
2005–2006 (n = 147) 33.3 19.7 19.7 4.8 0 29.2 33.4 30.8 12.2 38.1 52.4
2007–2009 (n = 138) 25.4 18.1 18.1 3.6 2.2 37.7 31.9 28.4 9.4 34.1 45.7
2010–2011 (n = 80) 20.0 8.8 8.8 5.0 1.2 31.3 33.8 28.7 7.5 28.8 42.5
AMP, ampicillin; AZT, azithromycin; CAZ, ceftazidime; CHL, chloramphenicol; CIP, ciproﬂoxacin; CRO, ceftriaxone; FZD, furazolidone; GEN, gentamicin; NAL, nalidixic
acid; STX, trimethoprim–sulfamethoxazole; TET, tetracycline.
*Includes resistant and intermediate strains.
†Difference from 2005 to 2011: p < 0.001.
‡Difference from 2005 to 2011: p = 0.009.
§Difference from 2005 to 2011: p = 0.014.
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FIGURE 2 | Minimum inhibitory concentrations to ciprofloxacin,
ceftriaxone, and azithromycin in Salmonella isolates from ill children
at a state referral hospital in Yucatan, Mexico, 2005–2011. Thick black
lines indicate breakpoints for resistance. Number of isolates for each
period was as follows: 2005–2006, n = 147; 2007–2009, n = 138, and
2010–2011, n = 80. (A) Ciproﬂoxacin MICs. Reduced susceptibility to
ciproﬂoxacin in Salmonella rose from 28% in 2005–2006 to 33% in
2010–2011. Non-susceptibility (MIC = 2) ﬁrst emerged in 2007 in a S.
Anatum isolate and later appeared in S. Typhimurium multidrug-resistant,
cephalosporin-resistant isolates. Black line is resistance breakpoint for
isolates from stools; red line is breakpoint for systemic infections. CLSI
breakpoints for susceptibility and resistance in isolates from stools are 1
and 4 μg/ml, respectively. Breakpoints for susceptibility and resistance in
isolates from systemic infections are 0.06 and 1 μg/ml, respectively.
(B) Ceftriaxone MICs. Resistance to ceftriaxone and other extended-
spectrum cephalosporins signiﬁcantly decreased from 19.7% during
2005–2006 to 8.8% in 2010–2011. Salmonella isolates were distributed
into two distinct populations, one which was susceptible and the other
resistant to ceftriaxone. CLSI breakpoints for susceptibility and resistance
are 1 and 4 μg/ml, respectively. (C) Azithromycin MICs. No signiﬁcant
changes in azithromycin MICs were noted. Suggested breakpoints for
susceptibility and resistance are 16 and 64 μg/ml, respectively
(Sjolund-Karlsson et al., 2011).
the exception of ciproﬂoxacin, declined in Salmonella. Resistance
to ESC continues to be prevalent among Salmonella isolates, and is
mediated by the blaCMY−2 gene. qnrB genes are widely distributed
among our Salmonella population, but their overall frequency
appear to be decreasing in recent years.
The increase in shigellosis in our pediatric population is a
major public health concern, as a high proportion of our patients
presented bloody diarrhea, high fever, and dehydration. The fre-
quency of seizures (11%), moreover, is much higher than that
reported in a recent study in Asia (3%; von Seidlein et al., 2006).
This could be explained by the higher proportion of S. ﬂexneri
infections at our center and by the fact that our study was con-
ﬁned to children with diarrhea sufﬁciently severe to seek medical
care at a hospital emergency room.
Our Shigella strains were frequently resistant to trimethoprim–
sulfamethoxazole and ampicillin, the ﬁrst line empirical therapy
for bloody diarrhea at our public hospitals. Although all strains
were susceptible to azithromycin, ESCs, and ciproﬂoxacin, none
of these antimicrobials are provided in oral form by our gov-
ernment healthcare system, which services 70% of the population.
Consequently, patientswith therapeutic failure ultimately required
hospitalization with parenteral ceftriaxone or out-of-pocket pur-
chase of oral azithromycin or ceﬁxime, escalating costs for both
the public health sector and families.
Although the increase in Shigella gastroenteritis was not statis-
tically signiﬁcant, we believe, nonetheless, that our ﬁndings are
epidemiologically and clinically signiﬁcant, as the prevalence of
Shigella gastroenteritis had never, during the last decade, reached
12%. It has remained at this level during 2012 and 2013 – a
worrisome trend that warrants close scrutiny by public health
authorities.
Our results concur with those of other investigators who
challenge the widely accepted notion of a worldwide decline in
shigellosis. Recent studies using active or passive surveillance have
detected high incidence rates of shigellosis in Peru, Thailand, and
China (Chompook et al., 2005; Kosek et al., 2008; Xia et al., 2011).
Unlike Southeast Asia (von Seidlein et al., 2006; Vinh et al., 2009),
where the dominant species has shifted from S. ﬂexneri to S. sonnei,
the former continues to be the major culprit of severe shigellosis
in Yucatan, as is the case in Peru and China.
The troubling recent rise in shigellosis could well be linked
to the current economy. Between 2008 and 2010, the number
of people below the poverty line in Yucatan increased by 35,000
(CONEVAL, 2012). Several independent studies have shown that
the risk factors for S. ﬂexneri infection include poverty and over-
crowded living conditions (Admoni et al., 1995; Kosek et al., 2008).
Interestingly, a massive spike in shigellosis has recently been
reported in the USA (Andrews, 2012).
In addition to a signiﬁcant decrease in Salmonella gastroenteri-
tis, isolates showed a downward trend in resistance to almost all
antibiotics, which was unrelated to changes in serovar distribu-
tion. The spread of ESC resistance to other serovars suggests that
the blaCMY−2 gene previously found in MDR S. Typhimurium
isolates in Yucatan (Zaidi et al., 2007) may have spread, as
noted in other reports (Arlet et al., 2006), through horizontal
transfer. There was remarkably little diversity of extended spec-
trum beta-lactamase genes as only blaCMY−2 was present in our
Salmonella strains. blaCMY−2 also predominates in Salmonella iso-
lates from humans, retail meat and animals in the USA (Zhao
et al., 2009; Folster et al., 2012), although blaCTX has been found
in almost 7% of clinical turkey isolates (Wittum et al., 2012). The
near absence of blaSHV, blaOXA, and blaCTX in the Salmonella
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Table 3 | Antimicrobial susceptibility in Shigella isolates from ill children inYucatan, Mexico, 2005–2011. Percentage of resistance*.
Year of isolation AMP CRO AZT CIP NAL CHL FZD† STX TET
2005–2006 (n = 73) 39.8 0 0 0 0 16.4 57.5 57.5 83.6
2007–2009 (n = 79) 44.3 0 0 0 1.3 24.1 25.4 59.5 92.4
2010–2011 (n = 66) 34.8 0 0 0 0 12.1 25.8 59.0 93.9
AMP, ampicillin; AZT, azithromycin; CAZ, ceftazidime; CHL, chloramphenicol; CIP, ciproﬂoxacin; CRO, ceftriaxone; FZD, furazolidone; GEN, gentamicin; NAL, nalidixic
acid, STX, trimethoprim–sulfamethoxazole; TET, tetracycline.
*Includes resistant and intermediate strains.
†Difference from 2005 to 2011: p < 0.001.
FIGURE 3 | Minimum inhibitory concentrations to ciprofloxacin,
ceftriaxone, and azithromycin in Shigella isolates from children with
gastroenteritis at a state referral hospital inYucatan, Mexico,
2005–2011.Thick black lines indicate breakpoints for resistance. Number of
isolates for each period was as follows: 2005–2006, n = 73; 2007–2009,
n = 79 and 2010–2011, n = 66. (A) Ciproﬂoxacin MICs. Isolates were fully
susceptible to ciproﬂoxacin throughout the study. Two isolates had
ciproﬂoxacin MICs ≥ 0.12 μg/ml, only one of which was resistant to
nalidixic acid. CLSI breakpoints for susceptibility and resistance are 1 and
4 μg/ml, respectively. (B) Ceftriaxone MICs. All isolates remained fully
susceptible to ceftriaxone with no changes over the study period. CLSI
breakpoints for susceptibility and resistance are 1 and 4 μg/ml,
respectively. (C) Azithromycin MICs. Suggested breakpoints are the same
as those proposed for Salmonella. Although isolates were apparently
susceptible to azithromycin throughout the study period, 7–17% of these
had an MIC = 16.
population of USA and Mexico strongly contrasts with reports
from Europe and Asia. Recent studies from Spain (de Toro et al.,
2011; Perez-Moreno et al., 2013) found an assortment of bla
genes in human Salmonella isolates, including blaTEM−1, blaSHV,
blaCTX−M , blaPSE−1, blaOXA, and blaDHA−1, while blaCTX−M ,
blaTEM, and blaSHV were more frequently found in poultry iso-
lates from the Netherlands (Dierikx et al., 2010). Likewise, blaTEM,
blaSHV, blaDHA, blaOXA, and blaCTX−M are common in non-
typhoidal salmonellae from humans and food-animals in India,
China, and Korea (Menezes et al., 2010; Tamang et al., 2011a; Yu
et al., 2011a). Diversiﬁcation of beta-lactamase genes depends on a
myriad of factors which include, among others, selective pressures
in the environment aswell as enzyme efﬁciency (Galan et al., 2013).
Unraveling the complexity of the evolutionary processes that lead
to the development of resistance and transfer of resistance genes
may allow us to better explain their different distributions around
the world.
Reduced susceptibility to ciproﬂoxacin and the presence of qnr
geneswas frequent in our Salmonella isolates; 32%presentedMICs
between 0.125 and 2 μg/ml, and 12% harbored a qnrA or qnrB
gene. These ﬁndings are comparable with those of other reports
fromLatinAmerica inwhich qnrB19 was the predominant variant.
It has been detected in Salmonella isolates from food in Colombia
(Karczmarczyk et al., 2010), and was highly prevalent in com-
mensal enterobacteria isolated from healthy children in Peru and
Bolivia (Pallecchi et al., 2009). Notably, it was also found in 32%
of screened individuals living in a remote village in the Amazonas
(Pallecchi et al., 2011). In contrast, a recent study conducted on
Salmonella isolates from humans, retail meat and animals in the
USA detected qnr genes in only 0.3% of human isolates, and none
from animal sources (Sjolund-Karlsson et al., 2010). qnr genes are
also reportedly low in China, Korea, and India (on the order of
0–3%), where aac(6′)-lb-cr is more commonly present (Menezes
et al., 2010; Tamang et al., 2011b; Yu et al., 2011b; Chen et al., 2012;
Kim et al., 2013). The origin and the mechanisms for widespread
dissemination of qnrB genes is currently unfolding. Recent evi-
dence points to the chromosome of Citrobacter spp. as the likely
origin of plasmid-mediated qnrB (Jacoby et al., 2011). The pres-
ence of qnrB19 genes on small colE-type plasmids (Karczmarczyk
et al., 2010; Pallecchi et al., 2010), as well as their insertion on
transposons located on larger plasmids (Cattoir et al., 2008; Dion-
isi et al., 2009) are believed to contribute to their dissemination
and persistence, even in the absence of selective pressure. This
could explain its ubiquity in commensal fecal ﬂora and horizontal
transfer and spread among unrelated species.
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Table 4 | Serotype distribution and antimicrobial susceptibility of Salmonella isolates positive for the qnr gene,Yucatan, Mexico, 2005–2011.
Qnr variant ID number Serotype Year of
isolation
Resistance phenotypes to
non-quinolone antibiotics
Ciprofloxacin
MIC (μg/ml)
Nalidixic acid
MIC (μg/ml)
A1 yuhs10-35 Enteritidis 2010 Nal, Fzd 1 128
yuhs05-13 Havana 2005 Amp, Sxt, Tet 0.5 32
yuhs05-87 Havana 2005 Amp, Sxt, Tet, Nal 0.5 16
yuhs05-106 Havana 2005 Amp, Sxt, Tet, Cro 0.5 16
B19 yuhs07-5 Adelaide 2007 Nal, Fzd 0.12 32
yuhs07-44 Adelaide 2007 Nal 0.5 64
yuhs07-71 Adelaide 2007 Nal 1 64
yuhs08-31 Adelaide 2008 Nal 1 64
yuhs07-40 Agona 2007 Nal 0.5 32
yuhs08-34 Agona 2008 Nal 1 64
yuhs07-38 Anatum 2007 Amp, Sxt, Tet, Nal, Cro 1 64
yuhs07-53 Anatum 2007 Amp, Sxt, Tet, Nal 2 128
yuhs09-10 Derby 2009 Tet, Nal 0.5 64
yuhs07-61 Enteritidis 2007 Nal, Fzd 1 64
yuhs08-57 Enteritidis 2008 Nal, Fzd 1 64
yuhs08-59 Enteritidis 2008 Nal, Fzd 1 64
yuhs09-1 Enteritidis 2009 Nal, Fzd 2 64
yuhs09-7 Enteritidis 2009 Nal, Fzd 1 64
yuhs11-43 Enteritidis 2011 Nal, Fzd 1 64
yuhs07-45 Havana 2007 Sxt, Tet, Chl 0.5 16
yuhs07-28 Muenchen 2007 Nal 1 32
B19 yuhs07-41 Muenchen 2007 Nal 1 32
yuhs08-8-1 Muenchen 2008 Nal 0.5 32
yuhs08-10 Muenchen 2008 Sxt, Nal 0.5 32
yuhs08-30-2 Muenchen 2008 Nal 0.5 32
yuhs11-33 Muenchen 2011 Nal 0.5 32
yuhs05-97 Muenster 2005 Amp, Sxt, Tet, Nal, Chl, Fzd 0.12 32
yuhs07-74-2 Muenster 2007 Sxt, Tet, Nal, Chl 1 32
yuhs07-75 Muenster 2007 Sxt, Tet, Nal, Chl 1 32
yuhs10-7 Muenster 2010 Sxt, Tet, Chl, Nal 1 32
yuhs11-10 Muenster 2011 Sxt, Tet, Chl, Nal 1 32
yuhs06-59 Reading 2006 Tet, Nal 1 32
yuhs06-60 Reading 2006 Tet, Nal 1 32
yuhs06-65 Reading 2006 Tet, Nal 1 32
yuhs07-78 Typhimurium 2007 Amp, Tet, Nal, Cro, Chl 1 32
yuhs07-79 Typhimurium 2007 Amp, Tet, Nal, Cro, Chl 1 32
yuhs07-9 Typhimurium 2007 Amp, Sxt, Tet, Nal, Cro, Chl 1 32
yuhs08-60 Typhimurium 2008 Amp, Sxt, Tet, Nal, Cro, Chl, Fzd, Gen 2 64
yuhs10-16 Typhimurium 2010 Amp, Sxt, Tet, Nal, Cro, Chl 0.25 32
yuhs11-28 Typhimurium 2011 Amp, Sxt, Tet, Nal, Cro, Chl 2 64
yuhs11-47 Typhimurium 2011 Tet, Chl, Nal 1 32
yuhs07-20 Untypable 2007 Nal 1 32
AMP, ampicillin; CHL, chloramphenicol; CRO, ceftriaxone; FZD, furazolidone; GEN, gentamicin; NAL, nalidixic acid; STX, trimethoprim–sulfamethoxazole; TET,
tetracycline.
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It is likely that many of our isolates with decreased suscepti-
bility to ciproﬂoxacin have mutations in the quinolone resistance
determining region, which was not assessed in this study. Fur-
thermore, several of our nalidixic acid-susceptible isolates with
reduced susceptibility to ciproﬂoxacin are likely to harbor other
resistance genes such asaac(6′)-lb-cr, qep, qnrC, and qnrD that have
been reported by other investigators. A more thorough search for
plasmid-mediated genes, nucleotide mutations in the DNA gyrase
and topoisomerase IV genes, as well as plasmid characterization
will be conducted in the future.
It is noteworthy that the prevalence of blaCMY−2 and qnr genes
decreased during the study period, possibly due to a reduced selec-
tive pressure in the regional Salmonella population. Although
detected in several other serovars, the blaCMY−2 gene is mainly
conﬁned to our S. Typhimurium isolates for which swine is the
major reservoir (Zaidi et al., 2007). Our qnr genes, on the other
hand, have dispersed more widely. In the Yucatan Peninsula, all
of the serovars harboring qnr genes are mainly associated with
swine except for S. Enteritidis, which is poultry-associated, and S.
Muenchen, which is more prevalent in cattle.
The encouraging decline in both the incidence and the antimi-
crobial resistance of Salmonella is likely due to interventions at
the farm level. During recent years, swine producers in Yucatan
have decreased the overall usage of antimicrobial compounds
by the implementation of stricter biosecurity measures, greater
use of vaccines, and stringent hygienic measures. Licensed vet-
erinarians are solely responsible for determining the antibiotic
regimens on farms (Jose Cervera, Asociacion Ganadera Local de
Porcicultores de Merida, personal communication). Our previous
molecular studies have shown that Salmonella strains in humans
closely reﬂect those of locally produced food-animals, particularly
swine (Zaidi et al., 2007). Improved farm management practices
would thus have a direct impact on zoonotic pathogens such as
Salmonella, but would be unlikely to have any effect on strictly
human pathogens such as Shigella, an assumption supported by
our study results. A comprehensive study in Denmark (World
Health Organization [WHO], 2003) showed that an overall reduc-
tion in usage of antimicrobial compounds in food-animals was
associated with decreased resistance in foodborne pathogens.
The epidemiology of Salmonella and Shigella in the Yucatan
Peninsula, as in other regions of the world, is evolving. Typhoid
fever and Shigella dysenteriae type 1infections, the major scourges
four decades ago, are now rare. The new challenges, as evi-
denced from this study, are MDR, ESC-resistant Salmonella with
rising resistance to ciproﬂoxacin and severe S. ﬂexneri gastroen-
teritis. Our ﬁndings underscore the need for greater efforts
to preserve critically important antibiotic classes such as ESC
and ﬂuoroquinolones. The agricultural sector in Mexico has
taken important steps to reduce the burden of salmonellosis.
Comparable action to ameliorate the impact of shigellosis is
urgently required. If worsening socioeconomic conditions are a
major determinant of this increase, action by health authori-
ties alone will not sufﬁce. Policy makers must take account of
the full consequences of social inequality and act accordingly
(Stiglitz, 2012).
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